Biomarkers related to immune checkpoint inhibitors therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biomarkers related to immune checkpoint inhibitors therapy

Published:2022-03 Issue: Volume:147 Page:112470
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Li Na,Hou Xin,Huang Shaogang,Tai Risheng,Lei Lei,Li Siyu,Abuliz Adina,Wang Geng,Yang Shanru

Funder

Ningbo Municipal Natural Science Foundation

National Natural Science Foundation of China

China Postdoctoral Science Foundation

University Nursing Program for Young Scholar with Creative Talents in Heilongjiang Province

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference114 articles.

1. A new member of the immunoglobulin superfamily--CTLA-4;Brunet;Nature,1987

2. PD-1 and PD-1 ligands: from discovery to clinical application;Okazaki;Int Immunol.,2007

3. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor;Nishimura;Immunity,1999

4. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells;Tseng;J. Exp. Med.,2001

5. Protein kinase C-eta controls CTLA-4-mediated regulatory T cell function;Kong;Nat. Immunol.,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Homologous recombination deficiency (HRD) is associated with better prognosis and possibly causes a non‐inflamed tumour microenvironment in nasopharyngeal carcinoma;The Journal of Pathology: Clinical Research;2024-08-05

2. Expression and function of VISTA on myeloid cells;Biochemical Pharmacology;2024-04

3. Automated tumor immunophenotyping predicts clinical benefit from anti‐PD‐L1 immunotherapy;The Journal of Pathology;2024-03-25

4. New strategies in the diagnosis and treatment of immune-checkpoint inhibitor-mediated colitis;World Journal of Clinical Cases;2024-02-26

5. Nanomaterials-based precision sonodynamic therapy enhancing immune checkpoint blockade: A promising strategy targeting solid tumor;Materials Today Bio;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3